You are here

Prescription: Washington

FDA Opens Door a Sliver to Gain Access to Investigational Drugs

New Policy’s Success Depends on Manufacturers
Stephen Barlas
PDF version: 
Stephen Barlas discusses the FDA’s position on greater availability of experimental drugs for critically ill patients.